Orbimed Advisors LLC Albireo Pharma, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$18.54 - $37.29 $3.6 Million - $7.23 Million
-194,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$23.94 - $33.74 $4.64 Million - $6.55 Million
194,000 New
194,000 $5.79 Million
Q4 2020

Feb 16, 2021
SELL
$31.56 - $42.16 $10.4 Million - $13.8 Million
-328,385 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$23.19 - $41.61 $7.62 Million - $13.7 Million
328,385 New
328,385 $11 Million

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email